At what age do children receive the Diphtheria, Tetanus, and Pertussis (DTaP) vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DTaP Vaccination Schedule for Children

Children receive the DTaP (Diphtheria, Tetanus, and Pertussis) vaccine in a five-dose series at ages 2 months, 4 months, 6 months, 15-18 months, and 4-6 years. 1

Standard Vaccination Schedule

The routine DTaP vaccination schedule consists of:

  • First dose: 2 months of age 1
  • Second dose: 4 months of age 1
  • Third dose: 6 months of age 1
  • Fourth dose (first booster): 15-18 months of age 1
  • Fifth dose (second booster): 4-6 years of age 1

Important Timing Considerations

Earliest Administration

  • The first DTaP dose can be administered as early as 6 weeks of age 1, 2
  • The fourth dose may be given as early as 12 months of age if at least 6 months have elapsed since the third dose 1

Minimum Intervals

  • A minimum interval of 4 weeks should occur between the first and second doses when an accelerated schedule is needed 1
  • The third dose should not be administered before 14 weeks of age 1
  • The fourth dose should be administered at least 6 months after the third dose and should not be given to children younger than 12 months 1

Special Circumstances

Fifth Dose Exception

A fifth DTaP dose is not necessary if the fourth dose was administered at age 4 years or older. 1 This is an important consideration to avoid unnecessary vaccinations.

Contraindications to Pertussis Component

For children with contraindications to the pertussis component, DT (Diphtheria and Tetanus Toxoids) should be used instead of DTaP to complete the age-appropriate series 1, 2

Clinical Pitfalls to Avoid

  • Late third dose increases risk: Children who receive the third dose late are significantly more likely to miss or receive the fourth dose late (24% vs 10% for on-time recipients) 3
  • Invalid fourth doses: Administering the fourth dose before 12 months of age or less than 6 months after the third dose results in an invalid dose that must be repeated 1
  • Brand mixing: While preferably the same manufacturer's DTaP should be used throughout the series, vaccination should not be delayed if the previous brand is unavailable 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Predictors of age-appropriate receipt of DTaP dose 4.

American journal of preventive medicine, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.